LH1307

Cat. No. M31306

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.

LH1307 is a C2-symmetric small molecule inhibitor of PD-1:PD-L1 interactions.

Molecular Weight	915.09
Formula	C54H58N8O6
CAS Number	2375720-38-8
Form	Solid
Solubility (25°C)	DMF 25.0 mg/mL DMSO 25.0 mg/mL Ethanol 10.0 mg/mL
Storage	-20°C

Related PD-1/PD-L1 Products
Avelumab (MSB0010718C) Avelumab is a whole monoclonal antibody of isotype IgG1 that binds to the programmed death-ligand 1 (PD-L1) and therefore inhibits binding to its receptor programmed cell death 1 (PD-1). Avelumab recognizes murine PD-L1
Panaxadiol Panaxadiol exists in ginseng root and has neuroprotective and anti-tumor functions. Panaxadiol inhibits the expression of programmed cell death ligand-1 (PD-L1) and tumor proliferation.
Fraxinellone Fraxinellone was isolated from the root bark of the brassica family Dictamnus dasycarpus. Fraxinellone is a PD-L1 inhibitor that inhibits HIF-1α synthesis without affecting HIF-1α degradation. Fraxinellone has potential for cancer immunity by targeting PD-L1.
BMS202 Bms-202 is an effective non-peptide PD-1/PD-L complex inhibitor with IC50 of 18 nM and KD of 8 μM. Bms-202 directly binds to PD-L1 and blocks the human PD-1/PD-L interaction. Bms-202 has antitumor activity.
Sulfamethoxypyridazine Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.

Catalog